SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001144204-12-048907
Filing Date
2012-08-30
Accepted
2012-08-30 12:45:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT TO S-3 v322742_posam.htm POS AM 28410
2 EXHIBIT 24.1 v322742_ex24-1.htm EX-24.1 8973
  Complete submission text file 0001144204-12-048907.txt   38480
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-156810 | Film No.: 121065147
SIC: 2835 In Vitro & In Vivo Diagnostic Substances